Anthelmintic activity of dioxapyrrolomycin.
Dioxapyrrolomycin, pyrrolomycin C, pyrrolomycin D, and piericidin C2 produced by UC 11065 were evaluated as anthelmintics. Assays used to examine these compounds included effects on the free-living nematode Caenorhabditis elegans, ability to clear target nematodes (Haemonchus contortus and Trichostrongylus colubriformis) from jirds, and clearance of Haemonchus contortus from lambs. A crude extract of UC 11065 containing dioxapyrrolomycin, pyrrolomycin C, pyrrolomycin D, and piericidin C2 was active against C. elegans and against H. contortus in the jird. Purified and/or synthetic samples of dioxapyrrolomycin, pyrrolomycin C, pyrrolomycin D, and piericidin C2 were tested in the jird model; only dioxapyrrolomycin exhibited appreciable activity against H. contortus (greater than or equal to 90.9% clearance at 0.33 mg/jird), while none of the compounds showed appreciable activity against T. colubriformis. Dioxapyrrolomycin cleared 99.9% of H. contortus from lambs at 12.5 mg/kg. An in vitro migration study using susceptible and closantel-resistant H. contortus showed there is cross-resistance between dioxapyrrolomycin and closantel. Dioxapyrrolomycin appears to be a narrow-spectrum anthelmintic which works through a closantel-like mode-of-action.
Conder
G A
GA
Upjohn Laboratories, Parasitology Research and Chemical and Biological Screening, Kalamazoo, Michigan 49001.
Zielinski
R J
RJ
Johnson
S S
SS
Kuo
M S
MS
Cox
D L
DL
Marshall
V P
VP
Haber
C L
CL
DiRoma
P J
PJ
Nelson
S J
SJ
Conklin
R D
RD
D000192:Actinomycetales / Q000378:metabolism; D000818:Animals; D000871:Anthelmintics / Q000302:isolation & purification / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000302:isolation & purification / Q000494:pharmacology*; D011758:Pyrroles / Q000302:isolation & purification / Q000494:pharmacology; D012756:Sheep
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D011758:Pyrroles; C053531:pyrroxamycin